HD-OPM Archive
Hashtags

#cosmos

31 posts

Cocoa flavanol extract cut CVD death 27% in the 21,000-person COSMOS trial

May 05, 2024 · Louis Nervegna ♥ 27 · 💬 53 ↩ 4 Nuts, fish, coffee, tea, cocoa & other foods

Louis summarizes the COSMOS randomized trial of 500 mg/day cocoa flavanols (and multivitamin) in over 21,000 adults for 3.6 years. Total cardiovascular events fell 10%, which was not statistically significant, but CVD death fell a significant 27% and major CV events were also significantly reduced. Adherence-adjusted analyses showed 15% fewer total events and 39% fewer CVD deaths; authors urge cautious interpretation.

COSMOS: cocoa flavanols cut cardiovascular death 27% in 21,000 adults over 3.6 years

Jul 19, 2024 · Louis Nervegna ♥ 23 · 💬 38 Nuts, fish, coffee, tea, cocoa & other foods

Reposting a summary of the COSMOS trial at Harvard/Brigham: more than 21,000 adults took 500 mg cocoa flavanols daily, a multivitamin, both or neither. Total CV events fell 10% (not significant), but CV death fell a significant 27%, with larger effects (15% total events, 39% for CV death-type outcome) among adherent participants.

COSMOS: RDA-level multivitamin slowed epigenetic aging by about 4 months

Mar 28, 2025 · Louis Nervegna ♥ 22 · 💬 9 Supplements & vitamins

Louis calls the COSMOS epigenetic-aging analysis arguably the highest quality RCT on multivitamins ever done. All five clocks showed a signal for slower aging, with significant effects on PCGrimAge and PCPhenoAge amounting to roughly 4 months of aging averted over 2 years, and larger effects in those with accelerated aging.

COSMOS: 2 years of a basic multivitamin slowed biological aging by about 4 months

Mar 09, 2026 · Louis Nervegna ♥ 9 · 💬 10 Supplements & vitamins

Latest COSMOS publication from Harvard and Mass General Brigham: a daily RDA-level multivitamin (Centrum Silver) slowed five epigenetic-clock measures of biological aging, with the largest gains in participants who were biologically older than their age at baseline. The poster stresses this was a standard multivitamin, not a megadose, and recalls that COSMOS earlier showed slower cognitive decline.

Multivitamin trials slow cognitive decline; possible relevance to heart disease patients

Jan 19, 2024 · Louis Nervegna ♥ 10 · 💬 12 Supplements & vitamins

Louis notes large randomized trials now show a basic RDA-level multivitamin can slow cognitive decline in older people. He speculates this could matter for heart disease patients because cognitive decline and heart disease are closely linked in older people, so a simple multivitamin might mitigate some added risk. The heart-specific benefit is a hypothesis, not shown in the post.

Daily multivitamin slowed cognitive aging by about two years in a COSMOS meta-analysis

Nov 14, 2026 · Louis Nervegna ♥ 7 · 💬 10 ↩ 1 Supplements & vitamins

Louis shares a summary of COSMOS cognition results: in the main analysis of 573 adults 60+, a daily multivitamin modestly improved overall cognition and episodic memory over two years. Pooling with two earlier COSMOS cognition studies (more than 5,000 older adults) gave clear benefits, estimated at about two years of slower cognitive aging. Effects were modest, it is unclear which nutrient matters, dementia prevention was not tested, and the manufacturer donated tablets. He adds that this was an RDA-level multivitamin (Centrum Silver).

Cocoa flavanols lower blood pressure and cut cardiovascular deaths 27% in COSMOS

Nov 14, 2026 · Louis Nervegna ♥ 15 · 💬 3 Blood pressure, salt & potassium

Louis shares a summary of cocoa flavanol evidence. An updated meta-analysis of 25 RCTs showed modest drops in blood pressure and improved flow-mediated dilation. The COSMOS trial gave 500 mg/day of flavanols to 21,442 older adults for a median 3.6 years, with total CV events down 10% (within chance) and CV deaths down 27%. A 2026 severity-ranked reanalysis favored cocoa.

COSMOS multivitamin matches Centrum-type RDA doses except B12 at 10x the RDA

Nov 15, 2026 · Louis Nervegna ♥ 7 · 💬 8 ↩ 2 Supplements & vitamins

Louis shows the ingredient list of the multivitamin used in the COSMOS trial next to the one used in Physicians' Health Study II. Nearly all nutrients are near RDA levels, but B12 is about 10x the RDA, and he suspects that dose may have driven the cognitive benefit seen in COSMOS. COSMOS showed slower cognitive decline in older adults, and PHS II showed an 8% cancer reduction.

Visceral fat had the strongest inflammatory protein signature of any trait in VITAL/COSMOS

Nov 05, 2026 · Louis Nervegna ♥ 10 · 💬 2 Weight, visceral & liver fat

Louis shares a cross-sectional proteomics analysis of 896 adults from VITAL and COSMOS. Visceral fat measured by DXA was associated with 221 circulating proteins, more than blood pressure, HDL, triglycerides or insulin resistance. It cannot prove causation, but suggests visceral fat is a meaningful target for reducing chronic inflammation.